SASS6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.283810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.438000E-01
Normal-vs-Stage2
1.462400E-01
Normal-vs-Stage3
1.090950E-01
Normal-vs-Stage4
8.179800E-01
Stage1-vs-Stage2
9.654000E-01
Stage1-vs-Stage3
1.864400E-01
Stage1-vs-Stage4
3.691000E-01
Stage2-vs-Stage3
9.726500E-02
Stage2-vs-Stage4
2.272000E-01
Stage3-vs-Stage4
5.580500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.374770E-01
Normal-vs-AfricanAmerican
4.001400E-01
Normal-vs-Asian
1.572180E-01
Caucasian-vs-AfricanAmerican
9.490200E-01
Caucasian-vs-Asian
6.727000E-01
AfricanAmerican-vs-Asian
8.455400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.529700E-02
Normal-vs-Female
2.458600E-01
Male-vs-Female
2.408600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.570000E-01
Normal-vs-Age(41-60Yrs)
1.835010E-01
Normal-vs-Age(61-80Yrs)
1.316750E-01
Normal-vs-Age(81-100Yrs)
2.183400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.412800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.665200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.404000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.476170E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.297800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.976600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.770200E-02
Normal-vs-Daily Drinker
1.484560E-01
Normal-vs-Weekly Drinker
1.520400E-01
Normal-vs-Occasional Drinker
2.835600E-01
Normal-vs-Social Drinker
3.797200E-01
Non Drinker-vs-Daily Drinker
5.224600E-01
Non Drinker-vs-Weekly Drinker
8.697600E-01
Non Drinker-vs-Occasional Drinker
5.921800E-02
Non Drinker-vs-Social Drinker
5.873700E-02
Daily Drinker-vs-Weekly Drinker
7.382200E-01
Daily Drinker-vs-Occasional Drinker
2.816600E-01
Daily Drinker-vs-Social Drinker
2.571200E-01
Weekly Drinker-vs-Occasional Drinker
1.971240E-01
Weekly Drinker-vs-Social Drinker
1.934020E-01
Occasional Drinker-vs-Social Drinker
8.634200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.467400E-01
Normal-vs-Grade 2
9.633200E-01
Normal-vs-Grade 3
9.301600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.835650E-01
Grade 1-vs-Grade 3
1.377810E-01
Grade 1-vs-Grade 4
9.467400E-01
Grade 2-vs-Grade 3
5.765600E-01
Grade 2-vs-Grade 4
9.633200E-01
Grade 3-vs-Grade 4
9.301600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.167800E-02
Normal-vs-NonDiabetic
1.090830E-01
Diabetic-vs-NonDiabetic
1.238840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.893040E-01
Normal-vs-NoPancreatitis
6.736200E-02
Pancreatitis-vs-NoPancreatitis
9.530200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.009800E-01
Normal-vs-N1
1.269590E-01
N0-vs-N1
6.517200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.607200E-01
Normal-vs-TP53-NonMutant
5.448800E-01
TP53-Mutant-vs-TP53-NonMutant
6.440100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
